Changes in Hong Kong stocks | Health Path (02587) rose more than 3% in the morning, and it is recommended to repurchase up to HK$100 million shares in the market

The Zhitong Finance App learned that the Path to Health (02587) rose more than 3% in the morning. As of press release, it had risen 2.67% to HK$4.99, with a turnover of HK$465.32,300.

According to the news, on December 8, Health Road issued an announcement. According to current market conditions, the Company plans to exercise a repurchase authorization to repurchase the Company's issued shares on the open market within the next five months, at a total cost of no more than HK$100 million (recommended repurchase). The Board believes that the proposed buyback reflects the company's confidence in its business prospects and will enhance shareholder value. Proposed repurchases will only be made when the Board of Directors deems it appropriate and in the overall interests of the Company and its shareholders.

Furthermore, the Board believes that the Company has sufficient financial resources to implement the proposed buyback and that it will not damage its financial position. The proposed repurchase will not be carried out in a way that causes the public shareholding of the shares to fall below the minimum percentage required by the listing rules, nor will it cause the Company's shareholders to make a mandatory comprehensive offer in accordance with the Company's Takeovers and Mergers Code.